The role of procalcitonin and lactate at single determination in the intensive care unit in the diagnosis and prognosis of hypovolemic and distributive (septic) shock

Introduction. The greatest difficulties arise in the differential diagnosis of hypovolemic or distributive (septic) shock. The aim of this study was to critically analyze the information value of the blood plasma content of lactate and procalcitonin (PCT) in patients with septic and hypovolemic shock.

Materials and methods. The diagnosis of «Sepsis» and «Septic shock» in the study was established according to the criteria of «Sepsis-3». 143 IRCs were filled, 34 of them with septic shock, 44 IRCs with hypovolemic, 65 IRCs with sepsis and organ dysfunction (OD).

Results. When determining the content of PCT in the blood plasma in patients with septic and hypovolemic shock, we found a statistically significant difference. The level of PKT in infectious shock —

33.3 (95% CI 7.9 — 58.0) ng / ml was higher than hypovolemic-0.9 (95% CI 0.43 — 6.45) ng/ml on average more than 30 times. In contrast to PCT, the content of lactate in the blood plasma did not carry a differential diagnostic value. Once measured at admission to the ICU, the level of PCT has no informational significance and does not indicate a likely outcome of the disease, complicated by the development of septic and hemorrhagic shock. Together with the low predictive ability of the nature of shock, lactate was highly informative in relation to the outcome of the disease, complicated by the development of shock syndrome.

Discussion. In our analysis, it is obvious that there were observations when the PCT level during hypovolemia was noticeably higher than normal, reaching a maximum of 6.4 ng / ml. Apparently, there was a combination of factors with an obvious activation of a trigger that affects its libration or the presence of endotoxinemia in hypovolemic shock in these specific patients. The informational value of PCT is not absolute and, according to meta-analyzes, is about 80%.

Conclusion. The blood content of procalcitonin in shock of an infectious nature was more than 30 times higher than the hypovolemic level on average. The informational value of procalcitonin in terms of predicting the course of the disease in septic and hypovolemic shock is absent. In the absence of predicting the nature of the shock, lactate is informative about the outcome of the shock. The possibility of increasing the blood lactate content in severe hemorrhagic shock with renal damage was noted.

1. Левит А. Л., Лейдерман И. Н., Крашенинников С. В. Шок. Классификация, диагностика и лечение. В кн.: Интенсивная терапия: национальное руководство: в 2 т./ под ред. Б. Р. Гельфанда, А. И. Салтанова. – М. : ГЭОТАР – Медиа, 2009. – т.I. с.229 -236.

2. Vincent J-L., De Baker D. Circulatory shock // N Engl J Med. – 2013; 369:1726– 1733, doi: 10.1056/NEJMra1208943.

3. Hernandez G., Teboul J-L. Fourth Surviving Sepsis Campaign ‘s hemodynamic recommendation: a step forward or a return chaos? // Crit Care. – 2017; 21:133, doi: 10.1186/s13054-017-1708-z.

4. Acute kidney injury in severe sepsis and septic shock in patients with and without diabetes mellitus: a multicenter study / Venot M, Weis L, Clec'h C. et al. // PLoS One. 2015;10: e0127411, doi: 10.1371/journal. Pone.0127411.1.

5. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multicenter derivation and validation study / Saeed K., Wilson D. C., Bloos F., et al. // Crit Care. – 2019; 23:40//doi: 10.1186/s13054-019-2329-5.

6. Procalcitonin as a diagnostic marker for sepsis: a systematic review and Meta –analysis / Wacker C., Prkno A., Brunkhorst F. et al. // Lancet Inf Dis. – 2013; vol.13 (5):426 – 435, doi: 10.1016/S1473-3099(12)70323-7.

7. Surviving Sepsis Campaign: International Guidelines for management severe sepsis and septic shock / Dellinger R., Levy M., Rhodes A. et al. // Crit Care Medicine 2012; 41: 296 – 327, doi: 10.1097/01.CCM.0000298158.12101.41.

8. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock / Rhodes A., Evans L., Alhazzani W. et al. // Intensive Care Med. –2017 Mar;43(3):304-377, doi: 10.1007/s00134-017-4683-6.

9. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) / Singer M., Deuschman C. S., Seymour C. W. et al. // Journal of the American Medical Association. 2016; 315(8):801-10; doi:10.1001/jama.2016.0287.

10. Использование шкалы qSOFA в диагностике сепсиса. Результаты российского многоцентрового исследования РИСЭС / Астафьева М. Н., Руднов В. А., Кулабухов В. В. и др. // Вестник анестезиологии и реаниматологии. – 2018. – Т. 15, № 4. – С. 14-22. DOI: 10.21292/2078-5658-2018-15-4-14-22 / qSOFA Score for diagnostics of sepsis. Results of the Russian multi-center trial of RISES / Аstafieva M. N., Rudnov V. А., Kulabukhov V. V. et al. // Messenger of Anesthesiology and Resuscitation, 2018. – Vol. 15, no. 4, P. 14-22. (In Russ.) DOI: 10.21292/2078-5658-2018-15-4-14-22.

11. Postoperative plasma concentrations of procalcitonin after different types of surgery / Meisner M., Tschaikowsky K., Hutzler A. et al. // Crit Care. – 1998, 2(1S): P040, doi: 10.1007/s001340050644.

12. Bakker J., Nijsten M., Jensen T. Clinical use lactate monitoring in critically ill patients. Ann Intensive Care 2013,3: 12, doi: 10.1186/2110-5820-3-12.

13. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3) / Shankar-Hari M., Phillips G. S., Levy M. L., et al. // JAMA. – 2016;315(8):775– 87. DOI: 10.1001/jama.2016.0289.

14. Assessment clinical criteria for sepsis for the Third International Consensus Definition for Sepsis and Septic Shock (Sepsis – 3) / Seymour Ch., Liu V., Ivashyna T. et al. // JAMA 2016, 315(8):762 – 764.

15. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature / Sponholz C., Sakt Y., Reinhart K., Brunkhorst F. // Crit Care 2006, 10: R145, doi: 10.1186/cc5067.

16. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis / Harbarth S. ; Geneva Sepsis Network // Am J Respir Crit Care Med. – 2001; 164:396 – 402, –doi: 10.1164/ajrccm.164.3.2009052.16.

17. Non-pulmonary infections but not specific pathogens are associated with increased risk of AKI in septic shock / Sood M., Mandelzweig K., Rigatto C. et al. // Intensive Care Med. – 2014; 40:1080–8, doi: 10.1007/s00134-014-3361-1.

18. Малкова О. Г., Петрищев Ю. И., Левит А. Л. Прокальцитонин, бактериемия и инфекционные осложнения после кардиохирургических операций. Вестник уральской медицинской академической науки. – 2017. – Том 14, № 1. – С. 12–18, – doi: 10.22138/2500-0918-2017-14-1-12–18 / O. G. Malkova, Y. I. Petrischev, A. L. Levit. Procalcitonin, bacteriemia and infectious complications after cardiac-surgical operations // Journal of Ural Medical Academic Science. – 2017. – Vol. 14, no. 1, pp. 12–18. – doi: 10.22138/2500-0918-2017-14-1-12–18 [In Russ.].

19. Мониторинг уровня SCD 14–ST (ПРЕСЕПСИНА) в периоперационном периоде у кардиохирургических больных / Попов Д. А., Плющ M. Г., Овсеенко, С. Т. и др. // Анестезиология и реаниматология. – 2013; 3: 30 -35.14, № 1, с. 12–18, doi: 10.22138/2500-0918-2017-14-1– 12–18 / Scd14-st (PRESEPSIN) level monitoring in cardiac surgical patients during perioperative period / Popov D. A., Plyush M. G., Ovseenko S. T . et al. // Messenger of Anesthesiology and Resuscitation – 2013, no. 3, P. 30-35. (In Russ.), doi: 10.22138/2500-0918-2017-14-1– 12–18.

20. For the KDIGO AKI Guideline Work Group: Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) / Kellum J. Lameire N. et al. // Critical Care 2013, 17:204, doi: 10.1186/cc11454.

21. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock / Kellum J. A., Chawla L. S., Keener C. et al. // Am J Respir Crit Care Med. – 2016; 193: 281–7, doi: 10.1164/rccm.201505-0995OC